Mannkind reported $308.32M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adma Biologics ADMA:US $ 308.03M 31.78M
Biocryst Pharmaceuticals BCRX:US $ 510.54M 17.18M
Chemocentryx CCXI:US $ 440.45M 14.8M
Dynavax Technologies DVAX:US $ 1023M 14.02M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Immunogen IMGN:US $ 422.3M 59.41M
Insmed INSM:US $ 1.05B 99.96M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Macrogenics MGNX:US $ 218.04M 53.4M
Mannkind MNKD:US $ 308.32M 12.84M
Minerva Neurosciences NERV:US $ 70.62M 6.5M
Novo Nordisk A Fs NVO:US $ 218928M 21792M
Peregrine Pharmaceuticals PPHM:US $ 429.84M 115.75M
Xencor XNCR:US $ 851.32M 6.6M